Aberrant expression of ISG15 has been demonstrated in most human malignancies, including ovarian cancer, suggesting it has a pro‐tumour function (Burks et al., 2014; Desai, 2015; Desai et al., 2006; Li et al., 2014). Here, ISG15 is linked to ovarian cancer.